Aug. 5 at 8:41 PM
$AQST Its an early sign but the charts are looking like the next push has started after the required pullback. Higher highs, higher lows from the last 3 trading sessions. We could see a push, going into the ER, back to
$4'teens,
$4.20's by Friday.
With Indivior reporting that Suboxone profits unexpectedly remained stable and maintained a 14% market share, the odds of a revenue beat are increasing. Which means revenue guidance remains intact, which is one of the main keys for success in an ER. I think they will spend just enough to make it so they meet expectations for eps and should still have enough cash on hand to make it to 1stQ 2026.
So with that I predict a revenue beat, with eps meeting expectations. Guidance unchanged. We are surely to get more information with the business update that will be attached to the ER, followed by the CC & Q&A the following day.
